Price $4.46 |
Market Cap
109.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.54
|
P/S
548.53
|
Dividend %
-
|
|
P/CF
6.9
|
P/FCF
12.7
|
Op. Cash Flow
10.6K
|
FCF
0.3
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-72.00%
|
ROI
-59.30%
|
|
ROA
-47.90%
|
EPS Growth
-10.60%
|
Current Ratio
8.9
|
Debt/Equity
10.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harrow Health Inc (HROW) | $6.65 | - | - | 180.6M | Strong Buy |
| Lannett Company, Inc. (LCI) | $0.59 | - | - | 24.5M | Strong Buy |
| Lineage Cell Therapeutics Inc (LCTX) | $1.61 | - | - | 285.1M | Strong Buy |
| LogicMark Inc (LGMK) | $1.23 | - | - | 11.8M | Strong Buy |
| Medicine Man Technologies Inc (SHWZ) | $1.00 | - | - | 52.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
